Dr. Reddy's Laboratories
212 hedge funds and large institutions have $1.51B invested in Dr. Reddy's Laboratories in 2023 Q3 according to their latest regulatory filings, with 33 funds opening new positions, 88 increasing their positions, 60 reducing their positions, and 14 closing their positions.
3,079% more call options, than puts
Call options by funds: $2.32M | Put options by funds: $73K
136% more first-time investments, than exits
New positions opened: 33 | Existing positions closed: 14
47% more repeat investments, than reductions
Existing positions increased: 88 | Existing positions reduced: 60
15% more capital invested
Capital invested by funds: $1.31B → $1.51B (+$199M)
9% more funds holding
Funds holding: 194 → 212 (+18)
3.13% more ownership
Funds ownership: 62.23% → 65.36% (+3.1%)
0% more funds holding in top 10
Funds holding in top 10: 2 → 2 (0)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Goldman Sachs
New York
|
+$68.1M |
| 2 |
BlackRock
New York
|
+$35.5M |
| 3 |
Robeco Institutional Asset Management
Rotterdam,
Netherlands
|
+$14.8M |
| 4 |
Renaissance Technologies
New York
|
+$12.7M |
| 5 |
Qube Research & Technologies (QRT)
London,
United Kingdom
|
+$8.98M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
-$50M |
| 2 |
Marshall Wace
London,
United Kingdom
|
-$14.8M |
| 3 |
Jane Street
New York
|
-$13.8M |
| 4 |
Man Group
London,
United Kingdom
|
-$10.5M |
| 5 |
Assenagon Asset Management
Senningerberg,
Luxembourg
|
-$8.7M |
RDY Hedge Fund Activity: Q3 2023 in Review
212 of the 6,310 institutional investors tracked by Wall St. Rank reported a position in Dr. Reddy's Laboratories (RDY) for Q3 2023, worth a combined $1.51B — up 15% from $1.31B a quarter earlier.
Buyers outnumbered sellers: 33 funds opened new RDY positions and 14 closed out — a net gain of 19 holders — while 88 added to existing stakes and 60 trimmed.
The largest buyer was Goldman Sachs, adding an estimated $68.1M. The largest seller was Royal Bank of Canada, cutting an estimated $50M.
- 212 institutional investors held Dr. Reddy's Laboratories (RDY) as of Q3 2023, up from 194 in Q2 2023.
- Funds reported $1.51B of Dr. Reddy's Laboratories stock for Q3 2023, up 15% quarter-over-quarter.
- 33 funds opened new Dr. Reddy's Laboratories positions in Q3 2023 and 14 closed out, a net change of +19 holders.
- The largest Dr. Reddy's Laboratories buyer in Q3 2023 was Goldman Sachs, an estimated $68.1M added.
- The largest Dr. Reddy's Laboratories seller in Q3 2023 was Royal Bank of Canada, an estimated $50M sold.
Based on aggregated 13F filings for Q3 2023.